ID   MYO1D_RAT               Reviewed;        1006 AA.
AC   Q63357; Q5PQU2;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2006, sequence version 3.
DT   02-OCT-2024, entry version 165.
DE   RecName: Full=Unconventional myosin-Id {ECO:0000303|PubMed:26446290};
DE   AltName: Full=Myosin heavy chain myr 4;
GN   Name=Myo1d; Synonyms=Myr4 {ECO:0000303|PubMed:8034741};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, SUBCELLULAR LOCATION, DOMAIN, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=8034741; DOI=10.1083/jcb.126.2.375;
RA   Baehler M., Kroschewski R., Stoeffler H.E., Behrmann T.;
RT   "Rat myr4 defines a novel subclass of myosin I: identification,
RT   distribution, localization, and mapping of calmodulin-binding sites with
RT   differential calcium sensitivity.";
RL   J. Cell Biol. 126:375-389(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, INTERACTION WITH CALMODULIN, DOMAIN, AND ACTIN-BINDING.
RX   PubMed=12719468; DOI=10.1083/jcb.200212039;
RA   Koehler D., Ruff C., Meyhoefer E., Baehler M.;
RT   "Different degrees of lever arm rotation control myosin step size.";
RL   J. Cell Biol. 161:237-241(2003).
RN   [4]
RP   FUNCTION, DOMAIN, INTERACTION WITH CALMODULIN, AND ACTIN-BINDING.
RX   PubMed=15853803; DOI=10.1111/j.1742-4658.2005.04642.x;
RA   Koehler D., Struchholz S., Baehler M.;
RT   "The two IQ-motifs and Ca2+/calmodulin regulate the rat myosin 1d ATPase
RT   activity.";
RL   FEBS J. 272:2189-2197(2005).
RN   [5]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=24903835; DOI=10.1002/jnr.23419;
RA   Yamazaki R., Ishibashi T., Baba H., Yamaguchi Y.;
RT   "Unconventional myosin ID is expressed in myelinating oligodendrocytes.";
RL   J. Neurosci. Res. 92:1286-1294(2014).
RN   [6]
RP   SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=26446290; DOI=10.1002/cm.21259;
RA   Hegan P.S., Ostertag E., Geurts A.M., Mooseker M.S.;
RT   "Myosin Id is required for planar cell polarity in ciliated tracheal and
RT   ependymal epithelial cells.";
RL   Cytoskeleton 72:503-516(2015).
RN   [7]
RP   RESCUE OF KUPFFER'S VESICLE LUMEN SIZE AND ANTERIOR-POSTERIOR CELL
RP   MORPHOLOGY DEFECTS, AND DOMAIN.
RX   PubMed=30139971; DOI=10.1038/s41467-018-05866-2;
RA   Saydmohammed M., Yagi H., Calderon M., Clark M.J., Feinstein T., Sun M.,
RA   Stolz D.B., Watkins S.C., Amack J.D., Lo C.W., Tsang M.;
RT   "Vertebrate myosin 1d regulates left-right organizer morphogenesis and
RT   laterality.";
RL   Nat. Commun. 9:3381-3381(2018).
CC   -!- FUNCTION: Unconventional myosin that functions as actin-based motor
CC       protein with ATPase activity (PubMed:12719468, PubMed:15853803). Plays
CC       a role in endosomal protein trafficking, and especially in the transfer
CC       of cargo proteins from early to recycling endosomes (By similarity).
CC       Required for normal planar cell polarity in ciliated tracheal cells,
CC       for normal rotational polarity of cilia, and for coordinated,
CC       unidirectional ciliary movement in the trachea. Required for normal,
CC       polarized cilia organization in brain ependymal epithelial cells
CC       (PubMed:26446290). {ECO:0000250|UniProtKB:F1PRN2,
CC       ECO:0000269|PubMed:12719468, ECO:0000269|PubMed:15853803,
CC       ECO:0000269|PubMed:26446290}.
CC   -!- SUBUNIT: Interacts (via the two IQ motifs) with calmodulin
CC       (PubMed:12719468, PubMed:15853803, PubMed:8034741). Binds an additional
CC       calmodulin chain via a third, C-terminal region (PubMed:8034741).
CC       Interacts with F-actin (PubMed:12719468, PubMed:15853803).
CC       {ECO:0000269|PubMed:12719468, ECO:0000269|PubMed:15853803,
CC       ECO:0000269|PubMed:8034741}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24903835,
CC       ECO:0000269|PubMed:8034741}. Perikaryon {ECO:0000269|PubMed:8034741}.
CC       Cell projection, dendrite {ECO:0000269|PubMed:8034741}. Early endosome
CC       {ECO:0000250|UniProtKB:F1PRN2}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:26446290}. Note=Colocalizes with the actin
CC       cytoskeleton in the cell cortex close to the apical cell membrane
CC       (PubMed:26446290). Colocalizes with cytoplasmic puncta that are
CC       reminiscent of transport vesicles (PubMed:8034741).
CC       {ECO:0000269|PubMed:26446290, ECO:0000269|PubMed:8034741}.
CC   -!- TISSUE SPECIFICITY: Detected on tracheal epithelial cells, and on
CC       epithelial cells and brush border cells in duodenum, jejunum and ileum
CC       (PubMed:26446290). Detected on myelinated white matter in the
CC       cerebellum, and the myelinated part of the optic nerve. Detected on
CC       mature oligodendrocites. Detected on the outside of the myelin sheet
CC       that surrounds axons (at protein level) (PubMed:24903835). Ubiquitous.
CC       Highest levels in adult brain, and spinal chord. Moderate levels in
CC       lung, kidney, liver and spleen. Low levels in testis and heart (at
CC       protein level). {ECO:0000269|PubMed:24903835,
CC       ECO:0000269|PubMed:26446290, ECO:0000269|PubMed:8034741}.
CC   -!- DEVELOPMENTAL STAGE: Not detected in brain one week after birth, prior
CC       to the onset of myelination, and levels are low two weeks after birth.
CC       Expressed at high and constant levels in brain after three weeks and
CC       later (at protein level) (PubMed:24903835). Expression is
CC       developmentally regulated during brain ontogeny, rising 2-3 week
CC       postnatally, and is maximal in adult brain (PubMed:24903835,
CC       PubMed:8034741). {ECO:0000269|PubMed:24903835,
CC       ECO:0000269|PubMed:8034741}.
CC   -!- DOMAIN: Binds a calmodulin chain via each of the two IQ domains
CC       (PubMed:12719468, PubMed:15853803). IQ domain 1 mediates interaction
CC       with calmodulin both in the presence and in the absence of Ca(2+). IQ
CC       domain 2 mediates interaction with calmodulin in the presence of Ca(2+)
CC       (PubMed:15853803, PubMed:8034741). {ECO:0000269|PubMed:12719468,
CC       ECO:0000269|PubMed:15853803, ECO:0000269|PubMed:8034741}.
CC   -!- DOMAIN: The TH1 domain is required for activity in complementing
CC       zebrafish defects in Kupffer's vesicle lumen size.
CC       {ECO:0000269|PubMed:30139971}.
CC   -!- DISRUPTION PHENOTYPE: Mutants display no defects in body left-right
CC       asymmetry, no obvious motor defects, and normal kidney and liver
CC       morphology. Tracheal epithelial cells display aberrant ciliary bending
CC       angles and disordered ciliary bending patterns. Likewise, planar cell
CC       polarity is disrupted in ependymal epithelial cells.
CC       {ECO:0000269|PubMed:26446290}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- CAUTION: Contrary to the situation in zebrafish, xenopus and
CC       drosophila, rat Myo1d defects have no effects on left-right body
CC       asymmetry. {ECO:0000269|PubMed:26446290}.
CC   -!- CAUTION: Represents an unconventional myosin. This protein should not
CC       be confused with the conventional myosin-1 (MYH1). {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X71997; CAA50871.1; -; mRNA.
DR   EMBL; BC087027; AAH87027.1; -; mRNA.
DR   PIR; A53933; A53933.
DR   RefSeq; NP_037115.2; NM_012983.2.
DR   AlphaFoldDB; Q63357; -.
DR   SMR; Q63357; -.
DR   BioGRID; 247518; 3.
DR   IntAct; Q63357; 1.
DR   MINT; Q63357; -.
DR   STRING; 10116.ENSRNOP00000004609; -.
DR   iPTMnet; Q63357; -.
DR   PhosphoSitePlus; Q63357; -.
DR   jPOST; Q63357; -.
DR   PaxDb; 10116-ENSRNOP00000004609; -.
DR   Ensembl; ENSRNOT00000004609.5; ENSRNOP00000004609.3; ENSRNOG00000003276.6.
DR   Ensembl; ENSRNOT00055042653; ENSRNOP00055034828; ENSRNOG00055024739.
DR   Ensembl; ENSRNOT00060053988; ENSRNOP00060044775; ENSRNOG00060031090.
DR   Ensembl; ENSRNOT00065031903; ENSRNOP00065025460; ENSRNOG00065018964.
DR   GeneID; 25485; -.
DR   KEGG; rno:25485; -.
DR   AGR; RGD:621321; -.
DR   CTD; 4642; -.
DR   RGD; 621321; Myo1d.
DR   eggNOG; KOG0164; Eukaryota.
DR   GeneTree; ENSGT00940000157411; -.
DR   HOGENOM; CLU_000192_7_7_1; -.
DR   InParanoid; Q63357; -.
DR   OrthoDB; 1094820at2759; -.
DR   PhylomeDB; Q63357; -.
DR   TreeFam; TF312960; -.
DR   PRO; PR:Q63357; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003276; Expressed in jejunum and 19 other cell types or tissues.
DR   GO; GO:0015629; C:actin cytoskeleton; IBA:GO_Central.
DR   GO; GO:0097440; C:apical dendrite; IDA:UniProtKB.
DR   GO; GO:0030673; C:axolemma; IDA:RGD.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; IDA:UniProtKB.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005902; C:microvillus; IBA:GO_Central.
DR   GO; GO:0043209; C:myelin sheath; IDA:UniProtKB.
DR   GO; GO:0016459; C:myosin complex; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IDA:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0000146; F:microfilament motor activity; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0030048; P:actin filament-based movement; IBA:GO_Central.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0030900; P:forebrain development; IEP:RGD.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   CDD; cd01378; MYSc_Myo1; 1.
DR   Gene3D; 1.10.10.820; -; 1.
DR   Gene3D; 1.20.5.4820; -; 1.
DR   Gene3D; 1.20.58.530; -; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR   Gene3D; 1.20.120.720; Myosin VI head, motor domain, U50 subdomain; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR010926; Myosin_TH1.
DR   InterPro; IPR036072; MYSc_Myo1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR13140; MYOSIN; 1.
DR   PANTHER; PTHR13140:SF417; UNCONVENTIONAL MYOSIN-ID; 1.
DR   Pfam; PF00612; IQ; 1.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF06017; Myosin_TH1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51757; TH1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; ATP-binding; Calmodulin-binding;
KW   Cell projection; Cytoplasm; Endosome; Motor protein; Myosin;
KW   Nucleotide-binding; Phosphoprotein; Protein transport; Reference proteome;
KW   Repeat; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O94832"
FT   CHAIN           2..1006
FT                   /note="Unconventional myosin-Id"
FT                   /id="PRO_0000123449"
FT   DOMAIN          9..695
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          699..719
FT                   /note="IQ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116,
FT                   ECO:0000305|PubMed:8034741"
FT   DOMAIN          721..741
FT                   /note="IQ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116,
FT                   ECO:0000305|PubMed:8034741"
FT   DOMAIN          812..1005
FT                   /note="TH1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01093"
FT   REGION          572..594
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   REGION          776..896
FT                   /note="Interaction with calmodulin"
FT                   /evidence="ECO:0000269|PubMed:8034741"
FT   BINDING         102..109
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:O94832"
FT   MOD_RES         200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94832"
FT   MOD_RES         536
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SYD0"
FT   CONFLICT        82
FT                   /note="A -> L (in Ref. 1; CAA50871)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1006 AA;  116095 MW;  ECD245C8ACACEA53 CRC64;
     MAEQESLEFG KADFVLMDTV SMPEFMANLR LRFEKGRIYT FIGEVVVSVN PYKVLNIYGR
     DTIEQYKGRE LYERPPHLFA IADAAYKAMK RRSKDTCIMI SGESGAGKTE ASKYIMQYIA
     AITNPSQRAE IERVKNMLLK SNCVLEAFGN AKTNRNDNSS RFGKYMDINF DFKGDPIGGH
     INNYLLEKSR VIVQQPGERS FHSFYQLLQG GSEQMLHSLH LQKSLSSYNY IRVGAQLKSS
     INDAAEFKVV ADAMKVIGFK PEEIQTVYKI LAAILHLGNL KFIVDGDTPL IENGKVVSVI
     AELLSTKADM VEKALLYRTV ATGRDIIDKQ HTEQEASYGR DAFAKAIYER LFCWIVTRIN
     DIIEVKNYDT TVHGKNTVIG VLDIYGFEIF DNNSFEQFCI NYCNEKLQQL FIQLVLKQEQ
     EEYQREGIPW KHIDYFNNQI IVDLVEQQHK GIIAILDDAC MNVGKVTDGM FLEALNSKLG
     KHGHFSSRKT CASDKILEFD RDFRIRHYAG DVVYSVIGFI DKNKDTLFQD FKRLMYNSSN
     PVLKNMWPEG KLSITEVTKR PLTAATLFKN SMIALVDNLA SKEPYYVRCI KPNDKKSPQI
     FDDERCRHQV EYLGLLENVR VRRAGFAFRQ TYEKFLHRYK MISEFTWPNH DLPSDKEAVK
     KLIERCGFQD DVAYGKTKIF IRTPRTLFTL EELRAQMLVR VVLFLQKVWR GTLARMRYKR
     TKAALTIIRY YRRYKVKSYI HEVARRFHGV KNMRDYGKHV KWPTPPKVLR RFEEALQSIF
     NRWRASQLIK TIPASDLPQV RAKVAAMEML KGQRADLGLQ RAWEGNYLAS KPDTPQTSGT
     FVPVANELKR KDKYMNVLFS CHVRKVNRFS KVEDRAIFVT DRHLYKMDPT KQYKVMKTIP
     LYNLTGLSVS NGKDQLVVFH TKDNKDLIVC LFSKQPTHES RIGELVGVLV NHFKSEKRHL
     QVNVTNPVQC SLHGKKCTVS VETRLNQPQP DFTKNRSGFI LSVPGN
//
